Table 4

Multiple logistic analysis between chronic kidney disease and dietary fiber intake
Odds ratio p for trend
Albuminuria ≥30 mg/g Model 0.92 [0.88-0.95] <0.0001
Model + obesity 0.93 [0.89-0.96] <0.0001
Model + elevated blood pressure 0.93 [0.89-0.96] <0.0001
Model + metabolic syndrome 0.93 [0.89-0.96] <0.0001
eGFR < 60 ml/min/1.73 m2 Model 0.94 [0.90-0.98] 0.006
Model + obesity 0.95 [0.90-0.99] 0.015
Model + elevated blood pressure 0.95 [0.91-0.99] 0.019
Model + metabolic syndrome 0.95 [0.91-0.99] 0.027
Chronic kidney disease Model 0.93 [0.90-0.96] <0.0001
Model + obesity 0.94 [0.90-0.97] 0.0005
Model + elevated blood pressure 0.94 [0.91-0.97] 0.0009
Model + metabolic syndrome 0.94 [0.91-0.98] 0.0011

Obesity: BMI ≥25.0 kg/m2; Elevated waist circumference, waist circumference ≥90 cm in males and ≥80 cm in females; Elevated blood pressure, systolic blood pressure ≥130 mmHg and/or diastolic blood pressure ≥85 mmHg and/or the use of antihypertensive drugs; Elevated triglyceride, fasting serum triglyceride ≥1.69 mmol/l and/or the use of triglyceride-lowering drugs; Low HDL cholesterol, fasting serum HDL cholesterol <1.03 mmol/l in males and <1.29 mmol/l in females. Metabolic syndrome was defined according to the definition of “Harmonizing the Metabolic Syndrome.” Model, multivariate adjustments with age, sex, duration of diabetes, current smoking habits, current drinking habits, total energy intake, fat intake, saturated fatty acid intake, protein intake, leisure time physical activity and use of oral hypoglycemic agents or insulin.

Fujii et al.

Fujii et al. Nutrition Journal 2013 12:159   doi:10.1186/1475-2891-12-159

Open Data